By tailoring interventions to specific molecular nodes—whether enhancing PINK1-Parkin flux in fibrosis, restoring SIRT3 activity in sepsis, or targeting FUNDC1 in hypoxia—researchers are pioneering strategies to break the cycle of mitochondrial dysfunction and inflammation. Here, PINK1 is linked to Sepsis.